H19 and colorectal carcinoma: The results revealed that H19 expression was an independent prognostic indicator for DFS (HR = 1.521, 95% CI, 1.303–1.896; P = 0.018) and OS (HR = 1.433, 95% CI, 1.239–1.786; P = 0.006) in patients with CRC (Table 2).